miR-181b modulates glioma cell sensitivity to temozolomide by targeting MEK1
- 5 May 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cancer Chemotherapy and Pharmacology
- Vol. 72 (1), 147-158
- https://doi.org/10.1007/s00280-013-2180-3
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Chemoresistance to Temozolomide in Human Glioma Cell Line U251 is Associated with Increased Activity of O 6-methylguanine-DNA Methyltransferase and Can be Overcome by Metronomic Temozolomide RegimenCell Biochemistry and Biophysics, 2011
- Alterations of microRNAs and their targets are associated with acquired resistance of MCF‐7 breast cancer cells to cisplatinInternational Journal of Cancer, 2010
- The use of hsa-miR-21, hsa-miR-181b and hsa-miR-106a as prognostic indicators of astrocytomaEuropean Journal of Cancer, 2010
- Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1Biochemical Pharmacology, 2010
- MicroRNA-221/222 Negatively Regulates Estrogen Receptorα and Is Associated with Tamoxifen Resistance in Breast CancerOnline Journal of Public Health Informatics, 2008
- hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cellsBrain Research, 2008
- Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicinMolecular Cancer Therapeutics, 2008
- Randomized Phase II Study of Temozolomide and Radiotherapy Compared With Radiotherapy Alone in Newly Diagnosed Glioblastoma MultiformeJournal of Clinical Oncology, 2005
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaThe New England Journal of Medicine, 2005
- MicroRNAs: Genomics, Biogenesis, Mechanism, and FunctionCell, 2004